Home 2013

February 2013 Vol. 8 No. 2

FDA issues proposed guidelines for developing drugs for Alzheimer’s disease
Aging

FDA issues proposed guidelines for developing drugs for Alzheimer’s disease

FDA approves Pomalyst for advanced multiple myeloma
Clinical Topics

FDA approves Pomalyst for advanced multiple myeloma

FDA approves new silicone breast implant
Clinical Topics

FDA approves new silicone breast implant

FDA approves first retinal implant for adults with advanced retinitis pigmentosa
Clinical Topics

FDA approves first retinal implant for adults with advanced retinitis pigmentosa

FDA approves Osphena for postmenopausal women with dyspareunia
Clinical Topics

FDA approves Osphena for postmenopausal women with dyspareunia

FDA warns of potential risk of liver injury in ADPKD patients taking Samsca
Clinical Topics

FDA warns of potential risk of liver injury in ADPKD patients taking Samsca

Study: ED charges vary widely
Clinical Topics

Study: ED charges vary widely

FDA approves new drug treatments for type 2 diabetes
Clinical Topics

FDA approves new drug treatments for type 2 diabetes

Study: Patients needing mental health care linger in EDs
Clinical Topics

Study: Patients needing mental health care linger in EDs

Study: Readmission rates don’t affect mortality
Cardio-Pulmonary

Study: Readmission rates don’t affect mortality

Study: Effects of childhood bullying persist into adulthood
Bullying

Study: Effects of childhood bullying persist into adulthood

Dangers of the 12-hour shift
Clinical Topics

Dangers of the 12-hour shift

Are Accountable Care Organizations doomed to fail?
Clinical Topics

Are Accountable Care Organizations doomed to fail?

123Page 1 of 3

Early Release Articles

Powered by  HCM   www.HealthComMedia.com

© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder